食品科学 ›› 2023, Vol. 44 ›› Issue (17): 36-42.doi: 10.7506/spkx1002-6630-20220801-008

• 基础研究 • 上一篇    下一篇

金属抗菌肽SIF4对大肠杆菌呼吸代谢与能量代谢的抑制机理

李玉珍,肖怀秋,刘淼,王琳,曾梦琪,赵谋明   

  1. (1.湖南化工职业技术学院制药与生物工程学院,湖南 株洲 412000;2.华南理工大学食品科学与工程学院,广东 广州 510000)
  • 出版日期:2023-09-15 发布日期:2023-09-29
  • 基金资助:
    湖南省自然科学基金科教联合基金项目(2022JJ60046)

Inhibitory Mechanism of Metal-Binding Antimicrobial Peptide SIF4 on Respiratory and Energy Metabolism of Escherichia coli

LI Yuzhen, XIAO Huaiqiu, LIU Miao, WANG Lin, ZENG Mengqi, ZHAO Mouming   

  1. (1. School of Pharmaceutical and Bioengineering, Hunan Chemical Vocational Technology College, Zhuzhou 412000, China; 2. School of Food Science and Engineering, South China University of Technology, Guangzhou 510000, China)
  • Online:2023-09-15 Published:2023-09-29

摘要: 为系统阐释金属抗菌肽SIF4对大肠杆菌呼吸代谢和能量代谢的抑制机理,本实验通过分析SIF4处理后大肠杆菌的代谢活力、呼吸抑制率、呼吸叠加率、细胞质膜离子通道ATP酶活力以及胞内ATP含量的变化情况,研究SIF4对菌体新陈代谢活力、呼吸代谢途径、细胞质膜离子通道ATP酶及胞内ATP生物合成的影响。代谢活力分析结果表明,随着SIF4处理剂量的增加,菌体代谢活力显著降低(P<0.05),2 倍最小抑菌浓度(minimum inhibitory concentration,MIC)组菌体代谢活力相比对照组降低了70.41%;呼吸抑制率分析结果表明,SIF4对菌体呼吸有较好的抑制活性,MIC组和2 MIC组呼吸抑制率分别为(19.387±0.168)%和(25.222±0.326)%;呼吸叠加率分析结果表明,金属抗菌肽与碘乙酸呼吸叠加率最低((19.982±0.133)%),由此可推断,SIF4主要通过抑制糖酵解途径实现高抗菌活性;SIF4处理后,细胞质膜离子通道Na+K+-ATP和Ca2+Mg2+-ATP酶活力均有不同程度下降,且降幅与处理剂量和时间呈正相关关系,但降幅均弱于阳性对照组(TritonX-100组);随着SIF4处理时间的延长和处理剂量的增加,胞内ATP含量显著降低,处理12 h时,与对照组相比,2 MIC组胞内ATP含量显著降低(P<0.05),但显著高于阳性对照组(P<0.05)。综上,金属抗菌肽SIF4可通过影响菌体呼吸代谢、削弱细胞质膜离子通道ATP酶活性和抑制胞内ATP合成实现对大肠杆菌的高效抑制,研究结果可为金属抗菌肽SIF4对食源性大肠杆菌生物防控提供理论支持。

关键词: 大肠杆菌;金属抗菌肽;呼吸代谢途径;能量代谢;抑菌机理

Abstract: This study aimed to systematically elaborate on the inhibitory mechanism of metal-binding antimicrobial peptide SIF4 on the respiratory and energy metabolism of Escherichia coli. By analyzing changes in the metabolic activity, individual and synergistic respiratory inhibition rate, cytoplasmic membrane ion channel ATPase and intracellular ATP level of E. coli after being treated with SIF4, the effects of SIF4 on the cell metabolic activity, respiratory metabolic pathway, cytoplasmic membrane ion channel ATPase and intracellular ATP biosynthesis were studied. Results showed that the metabolic activity of E. coli decreased significantly with increasing dose of SIF4 (P < 0.05), and decreased by 70.41% in the 2 × minimal inhibitory concentration (MIC) group compared with the control group. SIF4 had good inhibitory effect on the respiration of Escherichia coli, with an inhibition rate of (19.387 ± 0.168)% and (25.222 ± 0.326)% at MIC and 2 × MIC, respectively. The synergistic respiratory inhibition rate of SIF4 combined with iodoacetic acid was the lowest ((19.982 ± 0.133)%), indicating that SIF4 could exhibit high antimicrobial activity mainly by inhibiting the glycolysis pathway of E. coli. The activities of cytoplasmic membrane ion channel Na+K+-ATPase and Ca2+Mg2+-ATPase decreased after treatment with SIF4, and this effect was positively correlated with SIF4 dose and treatment time, but weaker than that of the positive control Triton X-100. As SIF4 dose and treatment time increased, the intracellular ATP concentration decreased significantly, and after 12 h, the intracellular ATP concentration in the 2 × MIC group was significantly lower than that in the control group but higher than that in the positive control group (P < 0.05). All results confirmed that SIF4 could exhibit high antimicrobial activity against E. coli by interfering with respiratory metabolism, weakening cytoplasmic membrane ion channel ATPase activity and inhibiting the biosynthesis of intracellular ATP, which can provide theoretical support for the biocontrol of foodborne E. coli.

Key words: Escherichia coli; metal-binding antimicrobial peptide; respiratory metabolic pathway; energy metabolism; antimicrobial mechanism

中图分类号: